In Brief
How Shigella can be infectious in humans despite lacking clear mechanisms for mucosal adhesion remains a longstanding enigma concerning its pathogenesis. Xu et al. demonstrate that Shigella exploits the host defense peptide HD5 in the gut to attain its ability to colonize and destroy the intestinal epithelium.
INTRODUCTION
Intestinal colonization and epithelial adhesion are crucial early events in the pathogenesis of many enteropathogens, which can then enable bacterial invasion of host epithelial cells and disseminated infection (Cossart and Sansonetti, 2004 ; Donnenberg, 2000; Pizarro-Cerdá and Cossart, 2006) . Most enterobacteria use fimbriae, an adhesive filamentous organelle protruding from the outer-membrane surface of Gram-negative bacteria, for host attachment (Choudhury et al., 1999; Kline et al., 2009; Li et al., 2009) . Paradoxically, Shigella, the etiological agent of bacillary dysentery, lacks such adhesion machinery in general, yet it is a remarkably infectious and contagious enteropathogen that invades and elicits intense inflammation and tissue damage of the colorectal epithelium (Carayol and Tran Van Nhieu, 2013; Perdomo et al., 1994; Phalipon and Sansonetti, 2007; Schroeder and Hilbi, 2008) . Despite a continued search for mechanisms of adhesion, the question of how Shigella has acquired extraordinary infectivity without a highly efficient and more general host adhesion apparatus remains unanswered. In studying the mode of action of antimicrobial peptides against Shigella, we found that when the human enteric a-defensin 5 (HD5), an abundant and important host protective molecule produced by Paneth cells of the small intestine (Bevins and Salzman, 2011) , binds Shigella, it augments infectivity via enhanced bacterial adhesion to and subsequent invasion of epithelial cells and tissues. We posited that Shigella subverts innate host defense to colonize and destroy the intestinal epithelium by turning HD5 into a molecular accomplice that imparts its infectivity and host selectivity.
RESULTS

HD5 Promotes Shigella Infection of Epithelial Cells
In Vitro Antimicrobial peptides, expressed primarily in phagocytes and epithelia, play critical roles in host immune defense against pathogenic infection often through microbicidal activity (Bevins and Salzman, 2011; Ganz, 2003; Lehrer and Lu, 2012; Selsted and Ouellette, 2005; Zasloff, 2002) . To study the role of antimicrobial peptides in Shigella pathogenesis, we tested a panel of six human and two murine defensin peptides against the Shigella flexneri strain Sf301 in an in vitro antibacterial activity assay (Ericksen et al., 2005; Mastroianni and Ouellette, 2009 ) including human neutrophil a-defensin 1 (HNP1), enteric a-defensins 5 and 6 (HD5 and HD6), b-defensins 2 and 3 (HBD2 and HBD3), the cathelicidin peptide LL-37, and murine a-defensins (cryptdins) 3 and 4 (Crp3 and Crp4). Whereas most of the human antimicrobial peptides displayed varying but weak bactericidal activity at low micromolar concentrations, HD6 and the two cryptdins showed little killing ( Figure S1A ). Weak antibacterial activity was also observed for HD5 with the Shigella sonnei strain Ss86 and five clinical isolates ( Figure S1B ). To test whether this antibacterial activity correlated with the ability of these peptides to inhibit Shigella infection in vitro, we quantified bacterial adhesion, invasion, and intracellular replication in a conventional infection assay by using HeLa cells ( Figure S2 ). When added to (C and D) The effects of HD5 treatment on Sf301 invasion (C) and proliferation (D) when added during initial infection (co-incubation) or after invasion (post-infection). Adhesion, invasion, and proliferation assays were performed as described in the STAR Methods. Experimental details are illustrated in Figure S2 . Data are shown as the mean ± SD of at least three independent experiments. Statistical significance was calculated (for peptide-treated samples compared with vehicle controls [0 mM]) with a one-way ANOVA (Dunnett's multiple-comparison test), and p values are as follows: *p < 0.05, **p < 0.01, ***p < 0.001. (E) Fluorescence microscopy (left) and scanning electron microscopy (right) analysis of Sf301 adhesion to HeLa cells in the absence (control) or presence of 4 mM HD5 (MOI = 50:1). GFP-expressing bacteria are green, b1 integrin is red, and nuclei are blue (DAPI). Scale bars represent 50 mm (fluorescent images) or 10 mm (SEM images). Error bars represent SD. (F) Confocal microscopy images of HeLa cells infected for 60 min with mCherry-labeled wildtype Sf301 harboring a GFP-expressing reporter plasmid (Campbell-Valois et al., 2014) in the presence or absence of 4 mM HD5. HeLa cells were counterstained with DAPI, and GFP expression was induced upon activation of a type 3 secretion system triggered by bacterial cell contact with the host. Note that red and green overlay gives rise to yellow. Scale bars represent 50 mm. Error bars represent SD.
Sf301, two human a-defensins, HNP1 and HD5, enhanced Shigella adhesion to and invasion of HeLa cells in an inoculum-dependent manner, such that the enteric a-defensin HD5 was markedly more active than its neutrophil counterpart HNP1 ( Figures 1A and 1B) . In fact, HD5 at 2 mM enhanced bacterial adhesion or invasion by more than 30-fold. Our subsequent study thus focused on HD5 not only for its site of abundant expression relevant to Shigella infection but also for its superior infection-enhancing activity.
Dissection of time-dependent cellular events in Shigella infection further revealed that HD5 acted early, predominantly at the bacterial infection step (adhesion and invasion) rather than on intracellular replication ( Figures 1C and 1D ). Similar results were obtained for HD5 with Shigella sonnei and also multiple clinical isolates (Figures S1C and S1D) . Consistent with these findings, immunofluorescence and scanning electron microscopy (SEM) studies showed that HD5-treated GFP-expressing or unlabeled Sf301 clustered on the surface of HeLa cells within 10 min of bacteria and HeLa coincubation ( Figure 1E ). To verify the viability of adhered Shigella, we transformed mCherry-labeled Sf301 (red) with a reporter plasmid that expresses GFP (green) when the type 3 secretion system (T3SS) is activated upon host cell contact (Campbell-Valois et al., 2014) , an obligate step in Shigella invasion, and found that HD5 treatment turned many clustered bacteria yellow (colocalized green and red) within 60 min of coincubation with HeLa cells ( Figure 1F ). Without host cells, HD5 alone failed to change the color of bacteria, as illustrated in Figures 1F and S1G , suggesting that it did not activate the T3SS directly. Furthermore, HD5 was found to promote strong adhesion of Shigella even when the T3SS, responsible for bacterial invasion and virulence, was inactivated either transcriptionally at low growth temperature (Maurelli et al., 1984) or genetically by deletion of spa33, encoding an essential component of the T3SS (Morita-Ishihara et al., 2006) ( Figure S1E ). In addition, HD5-enhanced Shigella infection was not restricted to HeLa cells (even though they are the standard in vitro infection model for Shigella; Philpott et al., 2000) , given that a wide variety of epithelial cell lines of different species and/or tissue origins were found equally susceptible ( Figure S1F and Table S1 ). Together, these results indicate that HD5 promoted Shigella infection in vitro by enhancing bacterial adhesion to epithelial cells and led to increased bacterial invasion.
HD5 Promotes Shigella Infection In Vivo
The impact of HD5 on the in vivo invasiveness of Shigella was extensively examined in three different animal models: (1) cornea infection in guinea pigs (the classic ''Sereny test'') (Sereny, 1955) , (2) colon infection in guinea pigs (Arena et al., 2015; Shim et al., 2007) , and (3) ileum and colon infection in mice (Sawasvirojwong et al., 2013) . For the Sereny test, Sf301 was inoculated in the eye at a density of 1 3 10 6 colony-forming units (CFU) per eye together with HD5 at 0, 4, and 8 mM; the severity of infection, graded from 1 to 3, was scored daily for 1 week ( Figure S3A ). Eye infection worsened over time such that the symptoms developed much more rapidly in the HD5-treated groups than in the control group. As shown in Figure 2A , in the absence of HD5, 3 of 15 animals developed full-blown keratoconjunctivitis and one showed signs of mild irritation after 1 week. By sharp contrast, in the presence of 4 mM HD5, the number of animals with high-grade keratoconjunctivitis increased to six in just 3 days ( Figure S3A ) and to 11 (of 15) in 1 week, and three animals died in the group treated with 8 mM HD5. Of note, treatment with HD5 alone at 8 mM had no adverse effects on the animals ( Figure 2A ). These data support that HD5 facilitated bacterial adhesion to and invasion of corneal epithelial cells in guinea pigs. In a second guinea pig model, anaesthetized animals were inoculated intrarectally with 1 3 10 8 CFU of HD5-treated, 1 3 10 8 CFU of mock-treated, or 1 3 10 9 CFU of mock-treated GFP-expressing Sf301 in 200 mL medium or with medium alone at equal volume (negative control). Animals were euthanized 4, 8, 24, and 48 hr after challenge, and the distal 10 cm of colon tissue was harvested for quantitative fluorescence imaging of Shigella infection as previously described (Arena et al., 2015) . Analysis of tissue-associated bacteria revealed that HD5-treated Shigella achieved a much greater early adhesion and colonization (both 4 and 8 hr after challenge) than the corresponding 1 3 10 8 CFU of mock-treated bacteria, as well as a higher inoculum (1 3 10 9 CFU) of mock-treated bacteria ( Figures 2B-2C and S3B). SEM imaging corroborated these results by showing extensive colonization of colonic crypts by HD5-treated Shigella ( Figure 2D ). Histological changes by bacterial infection in the colon at the later time points (24 and 48 hr) were examined by H&E staining (Figures 2E-2G ). All Shigella-inoculated animals showed some evidence of histopathology 24 and 48 hr after challenge, albeit to different extents. Without HD5 treatment, 1 3 10 8 CFU of Sf301 caused mild disruption of the luminal surface adjacent to the initial inoculating site 24 hr after challenge, whereas 1 3 10 9 CFU caused much more severe tissue damage during the same time period. HD5 potentiated the tissue damage (characterized by thickened submucosa and disruption of mucosal and submucosal layers) caused by 1 3 10 8 CFU of Sf301 by inducing edema, erosion, and crypt distortion comparable to those seen with 1 3 10 9 CFU. By 48 hr after initial inoculation, most of the histopathology caused by 1 3 10 8 CFU of Sf301 inoculum had healed, and the integrity of mucosa was almost restored. In contrast, comparable to infection with 10-fold higher inoculum (1 3 10 9 CFU) of Sf301 Shigella, the infection by 1 3 10 8 CFU of HD5-treated Sf301 bacteria showed worsened pathology after 48 hr. The initial infection loci expanded, and there was nearly complete destruction of mucosal and submucosal layers. Moreover, rather than a single major infection locus caused by Sf301 bacteria in each animal of the mock-treated groups, multiple (three to five) infection loci were identified in colonic tissue of each animal infected by HD5-treated Shigella 48 hr after challenge. These data are consistent with the conclusion that HD5-treated Shigella disseminated more extensively along the colonic tissue mucosa within 8 hr after initial inoculation than did mock-treated Sf301 bacteria. Of note, the irregular core body temperature of challenged animals, a representative sign of bacillary dysentery, showed a dramatic HD5-dependent effect. Whereas inoculation of 1 3 10 8 CFU of mock-treated Sf301 Shigella resulted in a marginal increase in body temperature within 48 hr, 1 3 10 8 CFU of HD5-treated bacteria caused severe fever in inoculated animals (an average increase by 1.3 C) from 24 hr, as did the high-inoculum (1 3 10 9 CFU) group ( Figure 2H ).
To extend the findings from the two guinea pig models, we adopted a well-established murine ileal and colonic loop model to investigate the impact of HD5 on the in vivo colonization and pathogenesis of Shigella (Sawasvirojwong et al., 2013) . Analysis of tissue-associated bacteria in mouse colonic and ileal loops confirmed that HD5-treated Shigella was much more robust in adhesion and colonization than mock-treated bacteria ( Figures  2I and 2J ). Together, our findings from three different animal models provide compelling evidence that HD5 can promote Shigella infection in vivo by enhancing bacterial adhesion to and invasion of epithelial tissues.
HD5 Exacerbates Shigella-Elicited Human Tissue Damage Ex Vivo
We cultured human colorectal explants as an ex vivo model to further investigate the role of HD5 in pathogenesis with human tissue ( Figure S3C ). SEM analysis revealed that HD5 significantly enhanced the adhesion of clustered Shigella cells to the colonic mucosa ( Figures 3A and 3B) . Histologically, human colonic tissues mock treated with medium or treated with HD5 alone at 8 mM displayed an intact lumenal epithelial layer and normal CFU of mid-log phase Sf301 per eye either in the absence (n = 15) or presence (4 mM [n = 14] or 8 mM [n = 14]) of HD5. A control group (n = 6) was inoculated with HD5 alone (8 mM). Animals were observed and scored for the development of conjunctivitis over 7 consecutive days. Eye pathology was independently scored by three individuals (blinded to treatment group) on a scale of 0-3: grade 0 (no disease or mild irritation), grade 1 (mild conjunctivitis or late development and/or rapid clearing of symptoms), grade 2 (keratoconjunctivitis without purulence), and grade 3 (fully developed keratoconjunctivitis with purulence) ( Figure S3A ). The data are representative of three independent experiments. Each point represents a single animal. Statistical significance of inoculation of 10 6 CFU in the presence compared with the absence of HD5 was determined with a MannWhitney test (*p < 0.05, **p < 0.01). Please also see Figure S3A for daily scoring. Colon histopathology scores at 24 hr (F) or 48 hr (G) (n = 5 each) were assigned as follows: 0, intact colonic architecture and no acute inflammation or epithelial injury; 1, focal minimal acute inflammation; 2, focal mild acute inflammation; 3, severe acute inflammation with multiple crypt abscesses and/or focal ulceration; and 4, severe acute inflammation, multiple crypt abscesses, epithelial loss, and extensive ulceration. Results are representative of three independent experiments and are shown as the mean ± SEM. Each point represents a single animal. Statistical significance of the HD5-treated group compared with 1 3 10 8 CFU of mock-treated Sf301 was determined with a Mann-Whitney test (*p < 0.05, **p < 0.01). (H) Core body temperature of animals 48 hr after challenge. Results are representative of three independent experiments and are shown as the mean ± SD. Each point represents a single animal (n = 9). Statistical significance between the indicated groups was determined by a one-way ANOVA (Tukey's multiple-comparison test; *p < 0.05, **p < 0.01).
(I and J) Ileum and colon infection model in mice. For the colon lops (I), a small abdominal incision was made in fasted, anesthetized mice, and two separate loops of colon were isolated by suture (2-3 cm in length). For each animal, one isolated colonic loop was instilled with 1 3 10 7 CFU of HD5-treated Sf301, and the second loop was instilled with mock-treated Sf301 (both in 100 mL medium). For the ileal-loop model (J), the same experimental approach was employed except that the two sutured loops were with the distal ileum. 2 hr after inoculation, mice were euthanized, and loops were harvested for quantitative fluorescence imaging of Shigella infection. Scale bars represent 50 mm. Results are shown as the mean ± SD. Statistical significance of the HD5-treated group compared with the group challenged with 1 3 10 7 CFU of mock-treated bacteria was calculated with a t test (*p < 0.05).
tissue architecture ( Figures 3C and 3D ). In the absence of HD5, samples inoculated with Shigella (1 3 10 6 CFU) showed disruption of the lumenal surface of epithelia, but the tissue architecture was largely maintained ( Figures 3C and 3D ). Co-inoculation of Shigella and HD5 led to a complete destruction of not only the epithelium but also its underlying tissue structure ( Figure 3D ). These results indicate that Shigella was capable of invading the human colonic epithelium and did so much more efficiently in the presence of HD5, thus further corroborating the proposed model of pathogenesis.
To provide additional support for the ex vivo study, we established an in vitro infection model by using a polarized epithelial monolayer of human Caco-2 cells as previously described (Mounier et al., 1992) . As shown in Figure 4A , the addition of 8 mM HD5 to the Caco-2 monolayer had limited impact over a period of 24 hr on its integrity and permeability, as measured by trans- (C and D) Analysis of histopathology of human colorectal explants 2 hr after inoculation with or without Sf301 in the absence or presence of HD5 (8 mM). Untreated (control) and HD5-treated specimens are included for comparison. Experimental details are described in the STAR Methods. Colon histopathology scores (C) were assigned as described above. Results are representative of three independent experiments and are shown as the mean ± SEM. Each point represents a colon sample. Statistical significance was determined with a Mann-Whitney test (*p < 0.05). Representative images of H&E staining (scale bars represent 100 mm) and SEM analysis (scale bars represent 500 mm) of colonic mucosa 2 hr after challenge are shown in (D). Please also see Figure S3C for the experimental procedure.
epithelial electrical resistance (TEER). Whereas Shigella alone was slowly destructive, a dramatically accelerated disintegration of the monolayer was evident in the presence of HD5. In fact, at 6 hr, compared with the mock-treatment group, HD5 treatment increased intracellular CFU by over 300-fold, presumably as a result of highly efficient bacterial invasion and cell-cell spreading of amplifying Shigella ( Figure 4B ). These results are consistent with fluorescence and SEM imaging studies showing that HD5 potentiated Shigella destruction of the tight junction of the epithelium ( Figure 4C ).
Human Luminal Fluids from the Small Intestine Promote
Shigella Infection In Vitro When maximally secreted, the concentration of HD5 in the lumen of the small intestine is estimated to be in the millimolar range (Ayabe et al., 2000; Ghosh et al., 2002; Ouellette, 2011) . However, unstimulated, the quantity of HD5 is far lower in aspirated small intestinal fluids from healthy donors undergoing routine screening colonoscopy, partly because of the large volumes of electrolyte solution needed to enable sampling. When such clinical aspirates collected from 17 individuals were analyzed directly, none were found active in enhancing Shigella adhesion to and invasion of HeLa cells in vitro. When concentrated and tested for activity in the infection assay, the ileal fluids became active in promoting Shigella infection in vitro ( Figures 4D, 4E , and S3D). The infectionenhancing activity was largely neutralized by anti-HD5 serum, indicating that HD5 in human luminal fluids from the small intestine contributed to Shigella infection in vitro. In addition, if exogenous HD5 (4 mM) was added to the intestinal fluid samples before concentration, they gained the ability to promote Shigella infection ( Figure S3E ), albeit to various degrees. These data support that the activity shown for 1-8 mM concentrations of HD5 in the in vitro and in vivo models of Shigella infection reported in the current investigation reflects similar activity reasonably anticipated during clinical infection in the human intestine.
Structural Basis of HD5-Enhanced Shigella Infection
The primary structures of epithelial defensins vary remarkably from species to species (Bevins and Salzman, 2011; Ganz, 2003; Lehrer and Lu, 2012; Selsted and Ouellette, 2005) . To elucidate the structural basis underlying HD5-promoted Shigella infection of host cells, we functionally analyzed a panel of 23 analogs of HD5 in an infection assay by using Sf301 and HeLa cells (Figures 5A and 5B) . Our data showed that (1) the native tertiary structure of HD5 was absolutely required, given that replacement of the six Cys residues by isosteric aminobutyric acid (Abu) to remove the three intra-molecular disulfide bonds of HD5 abolished adhesion and invasion enhancement; (2) whereas native HD5 readily dimerized, the dimerization-debilitating analog E21Me-HD5, in which the amide peptide bond is methylated at Glu21 to impair HD5 dimerization (Rajabi et al., 2012) , was largely inactive in promoting Shigella infection; (3) Ala replacement of bulky hydrophobic residues, particularly those in the C-terminal region of HD5 (such as Leu26, Tyr27, Data are shown as the mean ± SD from at least three independent experiments. Statistical significance was determined with a two-way ANOVA (**p < 0.01, ***p < 0.001). (B) Intracellular CFU of the polarized Caco-2 monolayer 6 hr after inoculation of Sf301 in either the absence or presence of HD5 (8 mM). Data are shown as the mean ± SD from at least three independent experiments. Statistical significance was determined with a t test (****p < 0.0001). (C) Disruption of the tight junction (as shown by immunofluorescence) and impairment of the integrity (as shown by SEM) of the epithelium. Polarized Caco-2 cells grown in Transwell inserts were infected with Sf301 in either the absence or presence of HD5 (8 mM) for 6 hr and then immunostained with antibody against the tight-junction marker ZO-1 (green). Nuclei were stained with DAPI (blue). Scale bars represent 50 mm. Invading bacteria in the polarized Caco-2 monolayer are indicated by red arrows in the SEM image. Scale bars represent 2 mm. (D and E) Effects of concentrated ileal fluid aspirates on Shigella Sf301 adhesion (D) and invasion (E) in comparison with DMEM either with or without HD5 (4 mM). Anti-HD5 antiserum was added to ileal fluids and HD5-containing DMEM at a dilution titer of 1:100 for examination of its neutralizing activity against Shigella infection promoted by endogenous HD5. Data are shown as the mean ± SD of at least three independent experiments. Statistical significance between indicated groups was determined with a one-way ANOVA (Tukey's multiple-comparison test), and p values are as follows: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. and Leu29), was functionally detrimental; and (4) Arg28 was a key residue for activity, although the other cationic Arg residues were functionally dispensable. Because Tyr27 and Arg28 appeared to be critically important residues, we crystallized both Y27A-HD5 and R28A-HD5 and determined their structures to be 1.75 and 2.4 Å , respectively ( Figures 5C and 5D ). The functionally inactive Y27A-HD5 existed as a monomer ( Figure 5E ), consistent with the fact that this residue, but not Arg28, is part of a contiguous hydrophobic core (along with Leu29) mediating HD5 dimerization. R28A-HD5 formed a canonical dimer similar to that of wild-type HD5 ( Figure 5F ) but was inactive, indicating that dimerization alone was not sufficient for activity. Rather, for the importance of Arg28, mutational and structural analysis identified in the HD5 dimer two amphipathic surfaces (comprising residues Leu16, Val19, Leu26, and Arg28; Figure 5G) , which most likely operate in tandem in interactions with molecular and cellular targets of the defensin. Together, these results highlight hydrophobicity and selective cationicity that are structurally segregated in a stable dimer as the most important molecular determinants of HD5 function. Of note, these structure-function determinants are in agreement with previous studies of antibacterial and antiviral activities of HD5 (Lehrer and Lu, 2012; Rajabi et al., 2012; Tenge et al., 2014) .
Fimbria Deficiency in Shigella Confers Its Sensitivity to HD5-Mediated Enhancement in Bacterial Infection
Type I fimbriae are the major components that impart host adhesiveness for many enterobacteria, such as E. coli and Salmonella (Edwards and Puente, 1998; Jones et al., 1995; Pizarro-Cerdá and Cossart, 2006 ), yet they are conspicuously absent from most Shigella strains, including Sf301 and many clinical isolates, as a result of independent mutations in the fim clusters (Bravo et al., 2015; Snellings et al., 1997) . To investigate the role of fimbriae in HD5-enhanced Shigella infection, we restored fimbria production in Sf301 by expressing the fim cassette from E. coli JM103 ( Figure 6A ). Whereas fimbria-expressing Sf301 showed much stronger basal adhesion to HeLa cells than wild-type Sf301, its improved adhesion capacity became largely insensitive to HD5 treatment ( Figure 6B ). Results paralleling these were found for E. coli BL21, the fimbria-deficient counterpart of JM103 of the same genetic background, as well as the fimA-deleted strain JM103 DfimA ( Figure 6C ). Similar to Shigella, the fimbria-expressing E. coli showed stronger basal adhesion to HeLa cells, but the enhanced adhesion became largely insensitive to HD5 treatment. Consistent with these results, HD5 promoted a substantial increase in adhesion to HeLa cells of the mutant strain SNP494 of Salmonella enterica serovar (for 1 hr) . The adhesion and invasion assays were as in Figure 1A , and data are expressed as the number of intracellular (A and B) and adhering (B) bacteria in HeLa cells relative to the input. Data are shown as the mean ± SD of at least three independent experiments. Statistical significance of mutant HD5 compared with wild-type HD5 (A) and the solvent control group (B) was determined by a oneway ANOVA (Dunnett's multiple-comparison test), and p values are as follows: *p < 0.05, **p < 0.01, ***p < 0.001. (C and D) The 2Fo-Fc electron-density map contoured at 1.0s of molecule A of Y27A-HD5 (C) and R28A-HD5 crystal (D) and the superimposition of defensin molecules present in the asymmetric units of analogs' crystals with the wild-type HD5 monomers (shown in gray; PDB: 1ZMP; Szyk et al., 2006) . Side chains of cysteines forming disulfide bridges and mutated residues are shown as sticks. Structural analysis of Y27A-HD5 and R28A-HD5 analogs confirmed that both mutant monomers assume the same fold as the wild-type HD5 monomer and have no major changes to the overall structure or the network of three disulfide bridges. When superimposed, the root-meansquare deviations (RMSD) between 128 equivalent main-chain atoms of wild-type HD5 and those of Y27A-HD5 and R28A-HD5 are in the range of 0.91-1.33 and 0.35-0.95 Å , respectively. (E and F) Crystal structures of the Y27A-HD5 monomer (E, green) and the R28A-HD5 dimer (F, yellow) superimposed on the wild-type HD5 dimer in gray (PDB: 1ZMP). Mutated residues and alanine substitutions are shown as spheres. (G) Key functional residues of HD5 forming putative binding surfaces for interactions with bacterial and host proteins. Positively charged Arg28 residues are colored in blue, and hydrophobic residues Leu16, Val19, and Leu26 are colored in green. Shades of green depict differences in activity, such that residues in light green are less important than those in dark green. Important residues not depicted in this view are Tyr27 and Leu29.
Typhimurium, whose fimbria and flagella were deleted (Chu et al., 2012) , despite having a lower basal adhesion level than its wild-type counterpart, IR715 ( Figures S4H and S4I) . Together, our findings demonstrate that although fimbria deficiency in Shigella conferred its poor ability to adhere intrinsically, this deficiency greatly augmented the ability of HD5 to mediate adhesion to host epithelial cells.
HD5 Targets Multiple Bacterial Membrane Proteins to Promote Shigella Adhesion to Host Cells
To better understand the mechanism of HD5-mediated adherence, we studied suspended HeLa cells and found that in the presence of HD5, Shigella preferably attached to the periphery of adhered, but not suspended, host cells, where the dynamic cell-substratum contacts occur (Figures S4A-S4C) . siRNAsilencing studies coupled with immunofluorescence staining suggested that integrins are involved as host factors in HD5-promoted Shigella adhesion ( Figures S4D-S4G) , consistent with their known ability to interact with a-defensins (Chavakis et al., 2004; Economopoulou et al., 2005) . These findings notwithstanding, HD5 primarily targeted the pathogen rather than host cells to enhance infection. Although HD5 can bind to both host and bacterial cells efficiently ( Figure S5A ), HD5 was substantially more effective at promoting bacterial infection when Statistical significance was determined with a twoway ANOVA, and p values are as follows: *p < 0.05, **p < 0.01, ***p < 0.001. (C) Host cell-adhesion activity of fimbriated and non-fimbriated E. coli strains in the absence or presence of HD5. Adhesion assays to HeLa cells were carried out with fimbriated E. coli (JM103), its fimbriaedeficient mutant (JM103 Dfim), and nonfimbriated E. coli (BL21). TEM images of these strains are shown on the right. Scale bars represent 500 nm. Statistical significance between indicated groups was determined with a t test, and p values are as follows: *p < 0.05, **p < 0.01, ***p < 0.001. Error bars represent SD. (D) Either Sf301 bacteria or the HeLa cells were pre-treated with HD5 at the indicated concentrations for 30 min and washed once with DMEM, and then the adhesion and invasion assays were performed. Data are shown as the mean ± SD of at least three independent experiments. Statistical significance of the HD5-treated group compared with the solvent control group (0 mM) at each time point was determined with a one-way ANOVA (Dunnett's multiple-comparison test), and p values are as follows: *p < 0.05, **p < 0.01, ***p < 0.001. (E) SEM and TEM analysis of Sf301 treated with HD5 or its linear analog (Abu-HD5). Scale bars represent 2 mm for SEM and 500 nm for TEM. (F) Immunogold TEM analysis of HD5 localization in Sf301-HeLa interaction in the presence of HD5. HD5 was labeled with $12 nm colloidal gold particles, and TEM was performed as described in the STAR Methods. B, bacterium; C, cell. Scale bars represent 500 nm. Please also see Figure S5B for more immunogold TEM images of HD5 bridging a single bacterium to a host and HD5 clustering multiple bacteria. (G) Relative adhesion ability of different Sf301 mutants in the presence of 4 mM HD5. spa33, icsA, ompA, ompC, and ompF and some combinations of two were ablated as described in the STAR Methods. Shigella strains were transformed with pBAD plasmids carrying the OmpC coding sequence and induced with 10 mM L-arabinose for OmpC expression. Please also see Figure S6F for SDS-PAGE analysis of the genetic ablations and recompletions. Adhesion assays were performed as in Figure 1A . Data are normalized to the input and shown as the percentage of the adherent bacteria of wild-type Sf301 in the presence of 4 mM HD5. Data are shown as the mean ± SD of at least three independent experiments. Statistical significance between mutants and the wild-type was determined with a one-way ANOVA (Dunnett's multiple-comparison test), and p values are as follows: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. pre-incubated with Sf301 than when pre-incubated with HeLa cells ( Figure 5D ). SEM, transmission electron microscopy (TEM), and immunogold-TEM studies revealed that HD5, but not its unstructured analog Abu-HD5, bound to the Shigella surface, formed patches of an ''adhesive'' structure, and lead to the clustering of Shigella cells and their adhesion to host cells ( Figures 6E, 6F, and S5B) .
To identify the bacterial targets with which HD5 directly interacts, we first investigated whether HD5, a known lectin capable of binding to glycosylated proteins (Lehrer et al., 2009) , could interact with the bacterial liposaccharide (LPS) to promote host adhesion by characterizing several LPS truncation mutants of Sf301. Our data ( Figures S6A-S6C) , however, showed that LPS was not targeted by HD5 for bacterial adhesion promotion. We next focused on potential proteinaceous targets of HD5 on the Shigella surface. Trypsin is the proteolytic processing enzyme of pro-HD5, and mature HD5 is stable to its hydrolytic activity (Ghosh et al., 2002) . Although it maintained bacterial viability, pre-treatment of Sf301 with trypsin lost HD5-augmented host adhesion capacity ( Figures S6D and S6E ), consistent with a proteinaceous target. HD5 enhanced bacterial adhesion to host cells within minutes of co-incubation and thus most likely targets preexisting surface components without involving the de novo protein synthesis and/or membrane shuttling machinery-a notion also supported by an adhesion assay using heat and paraformaldehyde-inactivated Sf301 (Figures S6G and S6H) .
Using the l red mutagenesis system (Datsenko and Wanner, 2000) , we genetically ablated Spa33, an essential component of the T3SS (Morita-Ishihara et al., 2006); IcsA, an autotransporter protein reported to function as an adhesin in hyperadhesive Shigella flexneri mutants lacking the T3SS component IpaD (Brotcke Zumsteg et al., 2014) ; and three of the most abundant outermembrane proteins, OmpA, OmpC, and OmpF (Ambrosi et al., 2012; Bernardini et al., 1993) . Deletion of Spa33, IcsA, OmpA, or OmpC in Sf301 led uniformly to a moderate drop in HD5-mediated adhesion ( Figure 6G) ; however, OmpF expression in Sf301 was undetectable ( Figure S6F ). As expected, a double genetic ablation of a combination of Spa33, OmpA, and OmpC (DOmpADOmpC in particular) further reduced bacterial adhesion. OmpC expression via plasmids not only restored adhesion of the OmpC-null mutant to above that of the wild-type but also increased HD5-mediated adhesion of the wild-type, OmpA-null, and OmpF-null strains ( Figure 6G ). Thus, our data indicate that multiple bacterial surface proteins collectively contribute to HD5-mediated adhesion.
DISCUSSION
The human a-defensin HD5 contributes to innate host defense against enteropathogens in the gut (Bevins and Salzman, 2011; Chu et al., 2012; Salzman et al., 2003) and helps maintain intestinal homeostasis by forming a chemical barrier that segregates the gut microbiota from host epithelium to limit tissue inflammation and microbial translocation (Belkaid and Hand, 2014; Bevins and Salzman, 2011) . Our biochemical and structural data, mechanistic and functional studies at the molecular and cellular levels, and in vivo and ex vivo findings all support that Shigella exploits HD5 for virulence and host infection. These results highlight that host defense factors such as a-defensins, which are vitally host protective (Bevins and Salzman, 2011; Selsted and Ouellette, 2005; Zasloff, 2002) , can be important contributors to pathogenesis when exploited by pathogens. Our work thus provides a noteworthy example of how immunity can serve as a ''double-edged sword'' in health and disease (Hansson and Libby, 2006) .
Our findings not only shed light on how Shigella adheres to and invades host cells despite its lack of fimbriae but also offer a clue on host-range selectivity of Shigella infection. Enteropathogens such as Salmonella and E. coli have a sophisticated adhesion apparatus, including fimbriae, flagella, and other adhesins, to ensure efficient bacterial colonization of the intestinal epithelium and subsequent invasion and infection (Donnenberg, 2000; Pizarro-Cerdá and Cossart, 2006) . Shigella, on the contrary, lacks such adhesion machinery in general (Bravo et al., 2015; Schroeder and Hilbi, 2008) and has a poor inherent ability to colonize host epithelium in vitro, confounding its extraordinary in vivo infectivity: 10-100 bacterial cells are sufficient to induce clinical symptoms in humans (DuPont et al., 1989) . Despite recent reports of two adhesion molecules of Shigella, IcsA and MAM, which operate only in specific biological settings (Brotcke Zumsteg et al., 2014; Mahmoud et al., 2016) , no efficient and general Shigella adhesin has been reported thus far. In fact, Shigella had long been thought to initially breach intestinal epithelial barriers through M-cell-mediated transcytosis, followed by dissemination to epithelial cells from the basolateral side (Carayol and Tran Van Nhieu, 2013; Cossart and Sansonetti, 2004; Phalipon and Sansonetti, 2007) . Our findings provide a compelling alternative hypothesis that secreted HD5 enables a mode of direct and active invasion by Shigella from the apical surface of the intestinal epithelium. We propose that Shigella, while in transit, encounters HD5 molecules in the small intestine and becomes highly adhesive and invasive as it reaches more distal sites in the colon. Given that HD5 is expressed by Paneth cells in the small intestine (Bevins and Salzman, 2011) , its high local concentration at the luminal surface of the small intestine is likely to be lethal to Shigella, which might then largely restrict bacterial adhesion and invasion to the downstream colonic epithelium, where HD5 is greatly reduced in abundance. Moreover, the finding that concanavalin A, a lectin that interacts with diverse host proteins containing mannose carbohydrates, failed to inhibit HD5-enhanced Shigella infection in vitro suggests a limited role played by mucin and/or surface glycoproteins in attenuating this HD5 activity in vivo. This direct invasion model reinforces a recent finding that Shigella primarily targets colonic crypts during the initial stages of mucosal invasion (Arena et al., 2015) .
It is plausible that Shigella could have undertaken a different evolutionary trajectory from Salmonella or E. coli to manifest its pathogenicity. Hijacking a host innate immune molecule to facilitate bacterial adhesion and invasion might provide an evolutionary advantage for Shigella, given that a lack of adhesive appendages such as fimbriae or flagella (Bravo et al., 2015) should help the pathogen evade host immune surveillance and thrive in the gut with significantly less anabolic burden. However, such a strategy that depends on a specific host factor would restrict host range, especially when targeting an epithelial a-defensin, where primary structures vary markedly from species to species.
Although it is not unusual for a microbial pathogen to exploit host components to promote its pathogenicity, our findings contribute a striking example of this phenomenon.
In addition, human neutrophil granular proteins containing a-defensins HNP1-HNP4 can enhance Shigella adhesion in vitro at sub-lethal concentrations (Eilers et al., 2010) , in accordance with our results on HNP1. Furthermore, both HD5 and HD6 have been reported to enhance HIV-1 infectivity in vitro by promoting virion attachment to target cells (Rapista et al., 2011) . However, both the molecular mechanisms and physiological implications of those findings remain to be determined. A very recent report found that a mouse adenovirus promotes its host entry in a receptor-independent manner by binding to mouse cryptdins and thus results in enhanced enteric viral infection (Wilson et al., 2017) , suggesting that pathogen exploitation of defensins for infection is not restricted to humans.
The precise molecular details underlying HD5-enhanced Shigella adhesion to epithelial cells and tissues need to be further clarified. HD5 is capable of binding to diverse molecular, bacterial, and viral targets in a multivalent, somewhat promiscuous fashion (Lehrer et al., 2009; Lehrer and Lu, 2012; Rajabi et al., 2012; Tenge et al., 2014) . It could serve as a bridging molecule to directly crosslink bacterial and host cells, as reported for HD5 and other mammalian defensins (Lehrer et al., 2009; Leikina et al., 2005) . Alternatively, by clustering Shigella cells, HD5 could endow the pathogen with a much-enhanced ability to adhere through multivalent high-avidity interactions between bacterial and host surface proteins. Cell-cell contact activates the T3SS, leading to Shigella invasion orchestrated by bacterial virulent effector proteins delivered by the T3SS into host cells (Cossart and Sansonetti, 2004; Donnenberg, 2000; Hauser, 2009; Pizarro-Cerdá and Cossart, 2006) . In the absence of an efficient host-adhesion apparatus of its own, HD5-promoted Shigella adhesion and colonization could potentiate T3SS activation, thus indirectly facilitating bacterial invasion and infection. Whether or not HD5 is capable of directly enabling Shigella invasion remains to be examined, though. Of note, shortening the LPS of Shigella increases accessibility of its T3SS tip to the host cell surface, thus augmenting T3SS activation and bacterial invasion (West et al., 2005) . Although HD5 did not target LPS directly to promote adhesion, the possibility that HD5 perturbs the LPS structure for enhanced T3SS activation and Shigella invasion cannot be formally excluded.
Finally, although Shigella is highly infectious in humans at an extremely low inoculum, it does not readily infect other animals. In fact, no suitable animal model is available to accurately recapitulate the pathogenesis of Shigella (Phalipon and Sansonetti, 2007) . Mice express abundant quantities of cryptdins in the intestine (Ouellette, 2011 ), yet they are relatively very resistant to oral Shigella challenge. Although this resistance could be due at least in part to the lack of IL-8 (Singer and Sansonetti, 2004) , the finding that mouse cryptdins, in contrast to HD5, are incapable of promoting Shigella adhesion and colonization suggests an alternative explanation for host specificity of this important human enteropathogen. Whether the lack of expression in other animals of an ortholog of HD5 capable of enhancing Shigella pathogenesis is sufficient to confer resistance to infection warrants additional investigation.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Ethics Approval
All the animals used in this study were acquired from the Experimental Animal Center of Xi'an Jiaotong University. The animal studies were approved by the Committee on Animal Research and Ethics, Xi'an Jiaotong University. All the animals were maintained in animal care facilities in the School of Life Science and Technology, and provided with food and water ad libitum. The use of healthy colonic tissues from patients undergoing surgery for colon cancer and the use of human small intestinal fluid aspirates from healthy donors undergoing routine screening colonoscopy were approved by the Ethics Committee of the Second Affiliated Hospital of Xi'an Jiaotong University School of Medicine. Informed consent was obtained from all patients.
Animal, Microbial, and Human Subjects
Female pathogen-free Hartley guinea pigs, aged 6-8 weeks and weighing 120-250 g, were used in the Sereny test and for the colon infection model. Female pathogen-free BALB/c mice, aged 8 weeks and weighing 20-30 g, were used for the ileal and colonic models of infection. Bacterial strains and cell lines are tabulated in the Key Resources Table, and human small intestinal fluid aspirates and colonic tissues from healthy donors are described in the Method Details below.
METHOD DETAILS Reagents
All peptides used in this study were chemically synthesized, correctly folded, and highly purified as previously described (Pazgier et al., 2013; Rajabi et al., 2012; Szyk et al., 2006; Wei et al., 2010; Wu et al., 2004; Wu et al., 2003) . Anti-human integrin b1 monoclonal antibody (MAB1959Z, P5D2) and anti-human integrin a5b1 monoclonal antibody (MAB1969, JBS5) were purchased from Millipore. Anti-human integrin b5 monoclonal antibody (#3629, D24A5) was purchased from Cell Signaling Technology. All common chemicals and reagents were purchased from Sigma-Aldrich unless indicated otherwise.
Bacterial Strains
Bacterial strains used in this study are listed in Table S2 . Shigella strains were cultured aerobically at 37 C in Tryptic Soy (TS) broth (Aoboxing, Beijing, China) or on TS agar plates with addition of 0.1% Congo Red. E. coli strains in this study were cultured in LuriaBertani (LB) broth (Aoboxing, Beijing, China) or on LB agar plates. Antibiotics (Sigma) were used as follows: ampicillin 200 mg/mL; kanamycin 100 mg/mL.
Strain Construction
Genetic ablation of Bacterial genes was performed using the l Red recombination system (Datsenko and Wanner, 2000) . Briefly, bacterial cells transformed with pKD46 were grown in the presence of L-arabinose to induce the expression of the lambda Red recombinase. A linear PCR product, amplified using the primers listed in Table S2 , containing a kanamycin-resistance cassette (KRC) flanked by FLP and 50 bp of the 5 0 -and 3 0 end homologous sequences of the target gene was electroporated into the bacterial cells and kanamycin was used to select the transformants. The plasmid pKD46 was eliminated by incubation at 37 C. To cure the kanamycin maker, pCP20 was introduced into kanamycin-resistant cells to elicit the recombination of flanking FLP sequences at both ends of the kanamycin cassettes. PCR screening for cured colonies were performed using specific primers listed in Table S2 . For OmpC and fimbriae re-expression experiments, the OmpC coding sequence from Sf301 and the fimbriae-expression cassette from E. coli JM103 (encoding FimA, I, C, D, F, G, H) were separately cloned into Nco I and Xho I sites of pBAD vector using the primers listed in Table S2 . Bacterial cells transformed with pBAD-OmpC or pBAD-Fim were cultured in LB with 10 mM L-arabinose to induce the expression of OmpC or production of fimbriae in Sf301. Bactericidal Assays Different bacterial strains ($10 6 CFU) were treated with the indicated concentrations of peptide in 500 mL DMEM (without serum) for 40 min at 37 C with mild agitation. After washing, the bacteria were diluted and plated. Bacterial viability was determined by colony counting and normalized against the viability observed with mock (PBS) treatment. Results are reported as the mean percentage of input bacteria of three independent experiments ± SD.
In Vitro Adhesion and Invasion Assay
The cell lines and their culture medium used in this study are listed in Table S1 . One day before the assays, cells were seeded into 24-well plates at a density of $10 5 cells per well. 1 hr before the infection, cell culture medium was changed into serum-free medium and $10 6 CFU Sf301 from mid-exponential phase was added to the cells together with a titration of HD5 (0-8 mM). Bacteria were centrifuged (2000 rpm, 10 min, RT) onto HeLa cells (MOI 10:1, or indicated MOI) to synchronize the infection. For the adhesion assay, after washing, the cells were lysed with 0.1% Triton/H 2 O and the CFU were enumerated after plating. For invasion and proliferation assays, bacteria/HeLa mixtures were incubated for 40 min after centrifugation and then washed, treated with gentamicin-containing (25 mg/mL) medium for another 1 hr (invasion) or 4 hr (proliferation) before being lysed for plating. Adhesion was defined as the total number of HeLa cell-associated bacteria and is shown as the percentage of input. Invasion and proliferation were defined as the total number of intracellular bacteria in cells (extracellular bacteria were killed by gentamicin, a cell-impermeable antibiotic). Average results of three independent experiments are reported as mean ± SD. For pre-treatment experiments, cells or bacteria were pre-incubated with HD5 at the indicated concentrations for 30 min, washed once with DMEM and then mixed to allow infection. Adhesion assays, invasion assays and proliferation assays were performed as stated above. Schematic illustration of the assays is shown in Figure S2 .
Sereny Test
Female specific pathogen-free Hartley guinea pigs, aged 6-8 weeks, weighing 120-250 g, were inoculated via conjunctival route with 10 6 CFU/eye of mid-log phase Sf301 in the absence or presence of 4 mM or 8 mM HD5 as described (Labrec et al., 1964) , with 15 animals in each group. The protocol was approved by the Committee on Animal Research and Ethics of Xi'an Jiaotong University. Inoculated animals were observed and scored for 7 consecutive days for the development of conjunctivitis. Eye tissues were scored by three individuals (DX, YS, YC) who were kept unaware of the treatment group on a scale of 0-3 defined as follows: grade 0 (no disease or mild irritation), grade 1 (mild conjunctivitis or late development and/or rapid clearing of symptoms), grade 2 (keratoconjunctivitis without purulence), grade 3 (fully developed keratoconjunctivitis with purulence). Statistical significance was calculated using a Mann-Whitney test.
Colon Infection Model in Guinea Pigs
Female pathogen-free Hartley guinea pigs, aged 6-8 weeks, weighing 120-250 g, were fasted for 24 hr and anesthetized by intraperitoneal injection of nembutal (30 mg/kg). Animals were inoculated intrarectally with either 1 3 10 8 CFU of HD5-treated, 1 3 10 8 CFU of mock-treated (low-inoculum positive control) or 1 3 10 9 CFU (high-inoculum positive control) of mock-treated GFP-expressing Sf301 in 200 mL medium. Animals inoculated with medium containing 8 mM HD5 at equal volume served as negative controls. HD5-treated Shigella bacteria were prepared as follows: 1 3 10 8 CFU of Sf301 were incubated with 8 mM HD5 in 50 mL DMEM for 20 min followed by centrifugation for 10-min. Most supernatant was decanted, leaving 200 mL to resuspend the bacteria. Temporally representative samples from colonic tissues were obtained at 4, 8, 24, and 48 hr after intrarectal challenge by euthanizing animals using nembutal. The distal 10 cm of colon was harvested and flushed with 4% (vol/vol) paraformaldehyde (PFA) in 13 PBS, inverted on wooden skewers, and kept in 4% PFA 13 PBS for 1-2 hr to complete fixation of the tissue and then incubated in 13 PBS glycine (100 mM) for 30 min to quench the PFA. Tissues were then immersed successively in 15% and 30% (wt/vol) sucrose at 4 C overnight. Tissues were removed from the skewers by a longitudinal incision and prepared as Swiss rolls (Arena et al., 2015) . Swiss rolls were then embedded in Tissue-Tek OCT compound (Sakura) using a flash-freeze protocol and frozen at À80 C. These OCTfrozen tissue preparations were cut as 20-mm-thick transversal sections. Tissues on slides were fixed with 4% PFA for 10 min at room temperature and permeabilized in PBS/0.2% Triton X-100 for 10 min. The slides were washed, mounted with Anti-Fade solution (Invitrogen) containing DAPI onto glass slides and visualized under a Zeiss confocal microscope. Shigella infection foci were identified by GFP fluorescence microscopy. The ten most bacteria-enriched fields from each group were analyzed, followed by automatic enumeration of individual Shigella bacteria using ImageJ 1.51k software (from http://imagej.nih.gov/ij).
Murine Ileal and Colonic Loop
Eight-week-old pathogen-free BALB/c mice (weight 20-30 g) were fasted for 24 hr and anesthetized by intraperitoneal injection of nembutal (60 mg/kg). While maintaining the body temperature at 37 using a heating pad, a small abdominal incision was made and two adjacent loops of either distal ileum or colon were isolated by suture (2-3 cm in length) in each animal. For each animal, one loop was instilled with 1 3 10 7 CFU of HD5-treated Sf301 (GFP-expressing), and the other was instilled with mock-treated Sf301 (both in 100 mL medium). HD5-treated Shigella bacteria were prepared as follows: 1 3 10 7 CFU of Sf301 were incubated with 8 mM HD5 in 5 mL DMEM for 20 min followed by centrifugation for 10 min. Most supernatant was decanted leaving 100 mL to resuspend the bacteria. The ileum (or colon) tissues were obtained 2 hr after inoculation, processed, and analyzed as described above for the colon infection model of guinea pigs.
Human Small Intestinal Fluid Aspirates
Ileal aspirates were obtained from healthy individuals who were undergoing routine screening colonoscopy for colon polyps. Prior to colonoscopy ($24 hr beforehand), patients were administered a routine polyethylene glycol-electrolyte solution to purge the bowel of contents, and the patients remained on clear fluids until the procedure was completed. During the colonoscopy procedure, the terminal ileum was intubated. Approximately 5-15 mL of ileal lumenal fluid was aspirated and immediately placed on ice. Specimens were clarified by centrifugation and filtered through a 0.22 mm filter. For some specimens, the fluid was further concentration by centrifugal filtration. The aliquots were stored in a freezer at À80 prior to analysis. The clarified fluid was used as the medium for Shigella infection assays.
Human Colorectal Explants
The human colorectal explants were established in accordance to a protocol recently developed by Tsilingiri et al. (2012) . Briefly, healthy colonic tissues were obtained from patients undergoing surgery for colon cancer. Tissue samples, maintained in Hank's balanced salt solution on ice, were transported to the laboratory and processed within 2 hr. The mucosa layer was separated from the underlying tissues, and then divided into pieces ($2-3 cm by $2-3 cm) and placed on soft agar (1% in PRMI 1640 medium) with the mucosal surface facing upward. A sterile cylinder (8 mm in inner diameter) was used to remove small pieces of soft agar under the center of the tissue segments and fresh medium was added to the small holes so that a small dip was formed at the center of the segment ( Figure S3C ). An aliquot (5 3 10 5 CFU) of Shigella from logarithmic growth culture in 10 mL of PRMI 1640 medium was added to the dip of the colon tissue and the explants were cultured in medium with or without 8 mM HD5 at 37 C for various times (from 30 min to 2 hr) in a cell culture incubator. Bacteria-free segments served as negative controls for each experiment and time point. Following incubation, infected explants were fixed in 10% buffered formalin, paraffin embedded and HE-stained for histopathological examination.
Measurement of Trans-epithelial Electrical Resistance (TEER)
Caco-2 cells (3 3 10 4 cells per well) were grown on 24-well transwell inserts with a 0.4 mm pore size (Corning) in 10% FBS DMEM. Five days after seeding, the polarized cells were placed in serum-free DMEM, and an aliquot of Sf301 bacteria (MOI = 50:1) was inoculated to the apical chamber either with or without HD5. The infected CaCo-2 cells were incubated for 60 min and then washed, treated with gentamicin-containing (50 mg/mL) medium. TEER values of the polarized epithelial monolayer were measured by Millicell ERS-2 Voltohmmeter (Merck Millipore) for 24 hr. Monolayers with TEER values within, 800-1200 U.cm 2 were considered to have an appropriate barrier function and were used in the study.
Crystallization, Data Collection, and Structure Determination Lyophilized HD5 mutant proteins were dissolved in water (20 mg/mL), mixed in a 1:1 ratio with precipitant solutions composed as listed in Table S4 and equilibrated at 22 in a hanging drop crystallization format. Crystals were flash frozen in liquid nitrogen after a brief soak in cryoprotectant solution (Table S4 ). Data were collected at the Stanford Synchrotron Radiation Light Source (SSRL) beamlines BL7-1 (Y27A mutant crystal form 1) and BL12-2 (Y27A mutant crystal form 2 and the R28A mutant). All data were processed and reduced with HKL2000 (Otwinowski and Minor, 1997) . Structures were solved by molecular replacement with the program Phaser (McCoy et al., 2007) from the CCP4 suite based on the coordinates of the 1ZMP wild-type HD5 monomer (Szyk et al., 2006) . Refinement was carried out with Refmac (Murshudov et al., 1997) and/or Phenix (Adams et al., 2010) and model building was done with COOT (Emsley et al., 2010) . Data collection and refinement statistics are shown in Table S5 . Ramachandran statistics were calculated with Molprobity and illustrations were prepared with Pymol Molecular graphics (http://pymol.org). Crystallographic data were collected at the Stanford Synchrotron Radiation Lightsource (SSRL), a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U. Immunofluorescence Microscopy Cells were plated onto glass coverslips and adhesion assays were performed as described using Sf301 harboring the GFP-expressing plasmid. Cells were fixed in 3% paraformaldehyde at room temperature for 15 min followed permeablization with 0.1%Trtion (in PBS) for 3-5 min, washed in PBS and blocked with 5% BSA (in PBS) for 30 min at room temperature. The coverslips were incubated with Actin, a5b1 or b1 antibodies at 4 C overnight followed by PBS washing and incubation with Alexa Fluor 594 secondary antibody (Invitrogen Molecular Probes, Carlsbad, CA) for 1 hr. The coverslips were washed, mounted with Anti-Fade solution (Invitrogen) containing DAPI onto glass slides and visualized under Zeiss confocal microscope.
Electron Microscopy
For scanning electron microscopy (SEM), adhesion assay was performed in the presence of 4 mM HD5 (MOI 50:1) as described above. Cells were fixed with paraformaldehyde (15min) and glutaraldehyde (overnight). The fixed specimens were dehydrated in graded ethanol, critical point dried with CO 2 and coated with gold-palladium beads with a diameter of 15 nm. Samples were photographed using a Philips XL-30 scanning electron microscope at 20 kV.
For transmission electron microscopy (TEM), bacteria (treated with or without HD5) were stained with 1.5% phosphotungstic acid for 90 s and examined by TEM (H-7650, HITACHI).
For immunogold-TEM, the adhesion assay was performed in the presence of 4 mM HD5 (MOI 50:1) as previously described. Cells were fixed in 3% paraformaldehyde at room temperature for 15 min followed permeablization with 0.1% Trtion (in PBS) for 3-5 min, washed in PBS and blocked with 5% BSA (in PBS) for 30 min at room temperature. Cells were then incubated with rabbit anti-HD5 antibody at 1:100 dilution at 4 C overnight, followed by PBS washing and incubation with 12 nm colloidal gold-conjugated donkey anti-rabbit IgG (H+L) for 2 hr at room temperature. Cells were washed and further fixed in 3% paraformaldehyde at room temperature for 15 min. Cells were collected by scratching and centrifugation. Further fixation was performed in 3% paraformaldehyde and 0.25% glutaraldehyde at 4 C overnight. Cell mass were embedded and cut into ultrathin sections as described, colloidal gold particles were recognized as dark spots under TEM (H-7650, HITACHI).
siRNA Silencing
The siRNA oligonucleotides were synthesized by Shanghai GenePharma (Shanghai, China) and their sequences are shown in Table S6 . Cells were transfected with siRNAs according to the recommended procedures of Lipofectamine 2000 Transfection Reagent (Invitrogen, Carlsbad, CA).
QUANTIFICATION AND STATISTICAL ANALYSIS
The data were collected from at least three independent experiments in triplicate or quadruplicate, unless otherwise indicated. Data were combined and represented as mean ± SEM or mean ± SD as indicated. Results were analyzed by various statistical tests using GraphPad Prism version 7. p < 0.05 was considered statistically significant. Microscopy images are representative of at least two independent experiments.
DATA AND SOFTWARE AVAILABILITY
The data that support the findings of this study are available from the corresponding author upon request. The Protein Databank accession numbers for the Y27A-HD5 and R28A-HD5 structures reported in this paper are PDB: 5CUM and 5CUI, respectively.
